MiR-218 Inhibited Growth and Metabolism of Human Glioblastoma Cells by Directly Targeting E2F2

Cellular and Molecular Neurobiology

Volumn 35, Issue 8, 2015, Pages 1165-1173

  Zhang, Yaxuan ^a   Han, Dongfeng ^a   Wei, Wenjin ^a   Cao, Wenping ^a   Zhang, Rui ^a   Dong, Qingsheng ^a   Zhang, Junxia ^a   Wang, Yingyi ^a   Liu, Ning ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

E2F2; Glioma; Metabolism; MiR 218; Proliferation

Indexed keywords

GLUCOSE; LACTIC ACID; MICRORNA; MICRORNA 218; TRANSCRIPTION FACTOR E2F2; UNCLASSIFIED DRUG; E2F2 PROTEIN, HUMAN; GROWTH INHIBITOR; MIRN218 MICRORNA, HUMAN;

ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER TISSUE; CELL CYCLE PROGRESSION; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; GLIOBLASTOMA; GLIOBLASTOMA CELL LINE; GLUCOSE INTAKE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUCIFERASE ASSAY; METABOLIC INHIBITION; PRIORITY JOURNAL; PROTEIN RNA BINDING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; BIOSYNTHESIS; BRAIN NEOPLASMS; GENE TARGETING; GENETICS; METABOLISM; PROCEDURES; TUMOR CELL LINE;

BRAIN NEOPLASMS; CELL LINE, TUMOR; E2F2 TRANSCRIPTION FACTOR; GENE TARGETING; GLIOBLASTOMA; GROWTH INHIBITORS; HUMANS; MICRORNAS;

EID: 84943818025     PISSN: 02724340     EISSN: 15736830     Source Type: Journal    
DOI: 10.1007/s10571-015-0210-x     Document Type: Article

References (21)

1. Babashah S, Soleimani M (2011) The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis. Eur J Cancer 47(8):1127–1137. doi:10.1016/j.ejca.2011.02.008
2. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281–297
3. Chen HZ, Tsai SY, Leone G (2009) Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nat Rev Cancer 9(11):785–797. doi:10.1038/nrc2696
4. DeGregori J (2002) The genetics of the E2F family of transcription factors: shared functions and unique roles. Biochim Biophys Acta 1602(2):131–150
5. Ivey-Hoyle M, Conroy R, Huber HE, Goodhart PJ, Oliff A, Heimbrook DC (1993) Cloning and characterization of E2F-2, a novel protein with the biochemical properties of transcription factor E2F. Mol Cell Biol 13(12):7802–7812
6. Kovesdi I, Reichel R, Nevins JR (1986) Identification of a cellular transcription factor involved in E1A trans-activation. Cell 45(2):219–228
7. Kovesdi I, Reichel R, Nevins JR (1987) Role of an adenovirus E2 promoter binding factor in E1A-mediated coordinate gene control. Proc Natl Acad Sci USA 84(8):2180–2184
8. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120(1):15–20. doi:10.1016/j.cell.2004.12.035
9. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the $$2^{{ - \Delta \Delta {\text C} {\text t}}}$$2-ΔΔCt Method. Methods 25(4):402–408. doi:10.1006/meth.2001.1262
10. Mathew LK, Skuli N, Mucaj V, Lee SS, Zinn PO, Sathyan P, Imtiyaz HZ, Zhang Z, Davuluri RV, Rao S, Venneti S, Lal P, Lathia JD, Rich JN, Keith B, Minn AJ, Simon MC (2014) miR-218 opposes a critical RTK-HIF pathway in mesenchymal glioblastoma. Proc Natl Acad Sci USA 111(1):291–296. doi:10.1073/pnas.1314341111
11. Nevins JR (1992) E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258(5081):424–429
12. Opavsky R, Tsai SY, Guimond M, Arora A, Opavska J, Becknell B, Kaufmann M, Walton NA, Stephens JA, Fernandez SA, Muthusamy N, Felsher DW, Porcu P, Caligiuri MA, Leone G (2007) Specific tumor suppressor function for E2F2 in Myc-induced T cell lymphomagenesis. Proc Natl Acad Sci USA 104(39):15400–15405. doi:10.1073/pnas.0706307104
13. Reimer D, Sadr S, Wiedemair A, Goebel G, Concin N, Hofstetter G, Marth C, Zeimet AG (2006) Expression of the E2F family of transcription factors and its clinical relevance in ovarian cancer. Ann N Y Acad Sci 1091:270–281. doi:10.1196/annals.1378.073
14. Reimer D, Sadr S, Wiedemair A, Stadlmann S, Concin N, Hofstetter G, Muller-Holzner E, Marth C, Zeimet AG (2007) Clinical relevance of E2F family members in ovarian cancer–an evaluation in a training set of 77 patients. Clin Cancer Res 13(1):144–151. doi:10.1158/1078-0432.CCR-06-0780
15. Setty M, Helmy K, Khan AA, Silber J, Arvey A, Neezen F, Agius P, Huse JT, Holland EC, Leslie CS (2012) Inferring transcriptional and microRNA-mediated regulatory programs in glioblastoma. Mol Syst Biol 8:605. doi:10.1038/msb.2012.37
16. Song L, Huang Q, Chen K, Liu L, Lin C, Dai T, Yu C, Wu Z, Li J (2010) miR-218 inhibits the invasive ability of glioma cells by direct downregulation of IKK-beta. Biochem Biophys Res Commun 402(1):135–140. doi:10.1016/j.bbrc.2010.10.003
17. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Eng J Med 352(10):987–996. doi:10.1056/NEJMoa043330
18. Suzuki DE, Nakahata AM, Okamoto OK (2014) Knockdown of E2F2 inhibits tumorigenicity, but preserves stemness of human embryonic stem cells. Stem Cells Dev 23(11):1266–1274. doi:10.1089/scd.2013.0592
19. Tu Y, Gao X, Li G, Fu H, Cui D, Liu H, Jin W, Zhang Y (2013) MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1. Cancer Res 73(19):6046–6055. doi:10.1158/0008-5472.CAN-13-0358
20. Wu N, Xiao L, Zhao X, Zhao J, Wang J, Wang F, Cao S, Lin X (2012) miR-125b regulates the proliferation of glioblastoma stem cells by targeting E2F2. FEBS Lett 586(21):3831–3839. doi:10.1016/j.febslet.2012.08.023
21. Yeh CT, Huang WC, Rao YK, Ye M, Lee WH, Wang LS, Tzeng DT, Wu CH, Shieh YS, Huang CY, Chen YJ, Hsiao M, Wu AT, Yang Z, Tzeng YM (2013) A sesquiterpene lactone antrocin from Antrodia camphorata negatively modulates JAK2/STAT3 signaling via microRNA let-7c and induces apoptosis in lung cancer cells. Carcinogenesis 34(12):2918–2928. doi:10.1093/carcin/bgt255